Oršolić, I., Bursać, S., Jurada, D., Drmić Hofman, I., Dembić, Z., Bartek, J. ... Volarević, S. (2020). Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint. Oncogene, 39. (17), 344-357. doi: 10.1038/s41388-020-1231-6
Oršolić, Ines, et al. "Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint." Oncogene, vol. 39, no. 17, 2020, pp. 344-357. https://doi.org/10.1038/s41388-020-1231-6
Oršolić, Ines, Slađana Bursać, Deana Jurada, Irena Drmić Hofman, Zlatko Dembić, Jiri Bartek, Ivana Mihalek and Siniša Volarević. "Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint." Oncogene 39, no. 17 (2020): 344-357. https://doi.org/10.1038/s41388-020-1231-6
Oršolić, I., et al. (2020) 'Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint', Oncogene, 39(17), pp. 344-357. doi: 10.1038/s41388-020-1231-6
Oršolić I, Bursać S, Jurada D, Drmić Hofman I, Dembić Z, Bartek J, and sur.. Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint. Oncogene [Internet]. 2020 February 27 [cited 2024 October 01];39(17):344-357. doi: 10.1038/s41388-020-1231-6
I. Oršolić, et al., "Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint", Oncogene, vol. 39, no. 17, pp. 344-357, February 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:956160. [Accessed: 01 October 2024]